Vazquez-Borrego MC, Gupta V, Ibanez-Costa A, Gahete MD, et al. A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors. Clin Cancer Res 2020;26:957-969.
PMID: 31624102